AVPT Insider Filing: Director Now Holds 89,801 Shares After RSU Award

Rhea-AI Filing Summary

Form 4 Overview – AvePoint, Inc. (AVPT)

Director Janet Schijns reported an equity transaction dated 20 June 2025. The filing shows the acquisition of 9,744 shares of AvePoint common stock (classified as restricted stock units, RSUs) at a stated price of $17.96 per share under the company’s 2021 Equity Incentive Plan. The RSUs represent a contingent right to receive one share of common stock for each unit upon vesting.

Vesting & Ownership

• 100 % of the RSUs vest on 1 June 2026, subject to the director’s continued service.
• Post-transaction beneficial ownership rises to 89,801 shares, held directly.

No derivative securities (options, warrants, etc.) were reported in Table II. The transaction was coded “A” (acquisition) and signed by Attorney-in-Fact Brian Michael Brown on 23 June 2025.

Investor Takeaways

• The filing indicates continued board-level alignment with shareholders through additional equity exposure.
• Because the award is in the form of RSUs rather than an open-market cash purchase, cash outlay by the insider is minimal; nevertheless, the grant’s delayed vesting may aid long-term retention.

Positive

• Director insider acquisition: 9,744 RSUs granted, increasing direct ownership to 89,801 shares, signalling continued alignment with shareholders.
• Long-term vesting schedule: 100 % vests on 1 June 2026, encouraging board member retention over multiple reporting cycles.

Negative

• None.

Insights

Securities Analyst

TL;DR: Director granted 9,744 RSUs, boosting stake to 89,801 shares—mildly positive alignment signal.

The RSU award increases insider exposure by roughly 11 % (9,744 ÷ 80,057 prior holding), lifting total direct ownership to 89,801 shares. Although the grant involves no cash purchase, the one-year lock until 1 June 2026 ties the director’s incentives to share performance over the next four fiscal periods. Such equity-based compensation is standard but can be read as a retention mechanism and potential vote of confidence. With no derivatives disclosed, dilution impact is negligible. From a valuation perspective, RSU expense has already been budgeted under ASC 718, so the transaction is unlikely to alter near-term earnings.

Corporate Governance Expert

TL;DR: Standard RSU grant; aligns director incentives, low governance risk.

This filing reflects routine board compensation rather than discretionary insider buying. Because the award vests in a single tranche, it promotes retention while keeping administration simple. No Rule 10b5-1 plan was indicated, and the signature is timely (filed within two business days), suggesting strong compliance. The lack of any simultaneous disposition limits the possibility of mixed signals. Overall, the event is governance-neutral to slightly positive for shareholder alignment.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SCHIJNS JANET

(Last) (First) (Middle)

C/O AVEPOINT, INC.

525 WASHINGTON BOULEVARD, SUITE 1400

(Street)

JERSEY CITY NJ 07310

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AvePoint, Inc. [ AVPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	06/20/2025		A		9,744(2)	A	$17.96	89,801	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This security represents the Issuer's common stock as well as restricted stock units (each, an "RSU") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.

2. 100% of the RSUs will vest on June 1, 2026, following the Reporting Person's continued service with the Issuer as of that vesting date.

	/s/ Brian Michael Brown, Attorney-in-Fact	06/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many AvePoint (AVPT) shares did Director Janet Schijns acquire?

She acquired 9,744 RSUs, each convertible into one share of common stock.

What is the vesting date of the reported RSUs for AVPT?

The RSUs fully vest on 1 June 2026, subject to continued service.

What is Janet Schijns's total beneficial ownership in AVPT after the transaction?

After the grant, she beneficially owns 89,801 shares of AvePoint common stock.

Was the AvePoint transaction an open-market purchase?

No. The Form 4 lists transaction code “A” (acquisition) and identifies the shares as RSUs granted under the company’s equity plan.

When was the Form 4 for AVPT filed?

The document was signed on 23 June 2025 and covers a transaction dated 20 June 2025.